Morganroth, M L <br/><br/>
Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Mar 1988 
 - 316-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0023-6837 
<br/><br/><label>Subjects--Topical Terms: </label><br/>6-Ketoprostaglandin F1 alpha--metabolism<br/>Animals<br/>Blood Pressure<br/>Capillary Permeability<br/>Chromatography, High Pressure Liquid<br/>Complement Activation<br/>Cyclooxygenase Inhibitors<br/>Elapid Venoms--pharmacology<br/>Hypertension, Pulmonary--etiology<br/>Indomethacin--pharmacology<br/>Leukotriene B4--metabolism<br/>Lipoxygenase Inhibitors<br/>Lung--drug effects<br/>Male<br/>Naphthols--pharmacology<br/>Organ Culture Techniques<br/>Rats<br/>SRS-A--metabolism<br/>Thromboxane B2--metabolism